SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-08-014631
Filing Date
2008-06-09
Accepted
2008-06-09 15:57:25
Documents
2
Period of Report
2008-06-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 1765
2 POWER OF ATTORNEY poa1.htm EX-24.1 5713
  Complete submission text file 0001140361-08-014631.txt   9373
Mailing Address 341 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 341 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Issuer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2483 EAST BAYSHORE ROAD SUITE 100 PALO ALTO CA 94303
Business Address 650-526-6800
Ketchum Steven B (Reporting) CIK: 0001289884 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-51531 | Film No.: 08888176